The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030)
상품코드:1790502
리서치사:Kalorama Information
발행일:2025년 09월
페이지 정보:영문 1,275 Pages
라이선스 & 가격 (부가세 별도)
한글목차
「세계의 체외 진단 검사 시장 : 제18판(2025-2030년) 」은 체외 진단용 의약품 업계에 관심을 가지고 계신 분, 또 업계에 종사하는 분에게 있어 필수 불가결한 자료입니다. 이 종합적인 보고서는 신뢰할 수 있는 추정치, 2025년부터 2030년까지 실세계 예측, 체외 진단 검사 시장 전체를 이해하는 데 필요한 중요한 인사이트를 제공합니다. 주요 검사 카테고리를 상세하게 다루고 있으며, 10유형 시장 조사 보고서를 1권으로 정리한 종합적인 내용이 되고 있습니다.
주요 특징
광범위한 조사 범위 : 임상 화학, 혈액학, 조직학, 분자 생물학, 면역학, 감염, 응고, 혈액 은행 체외 진단(IVD), POC(Point-of-Care) 등 주요 체외 진단(IVD) 검사 범주별로 상세한 추정 및 예측을 제공합니다.
상세한 분석 : 이 1,700페이지의 보고서는 공급업체 보고서, 인터뷰 및 세계 활동을 기반으로 체외 진단용 의약품 시장에 대한 완전한 평가를 제공합니다.
신뢰할 수 있는 출처 : 1999년부터 발행되었으며 체외 진단용 의약품 업계의 최고 기업에서 가장 신뢰받는 보고서입니다.
성장 예측 : 2030년까지 모든 검사 분야 시장 규모, 예측, CAGR.
엔터프라이즈 프로파일 : 상위 40개 기업을 포함한 수백 개의 상세한 엔터프라이즈 프로파일 : 게재, 실적, 제품 발표 및 전략적 계획을 다룹니다.
세계 범위 : 분석에는 세계 주요 국가 및 주요 시장 부문 시장 규모가 포함됩니다.
사업계획에 필수적인 인사이트
시장 규모와 동향 : 체외 진단용 의약품 시장 규모와 시장 내역을 파악할 수 있습니다.
예측 : 5년 후 시장 예측을 정리했습니다.
산업 변화 : 체외 진단용 의약품 시장의 경년 변화를 추적합니다.
경쟁 구도 : 주요 진출기업, 합병 및 획기적인 제품 출시를 확인합니다.
전략적 기회 : 진입 또는 투자가 가능한 성장 시장을 발견합니다.
국가별 범위 :
이 보고서는 세계의 체외 진단 검사 시장 조사 범위를 반영합니다.
지역 미국, 유럽, 아시아태평양, 라틴아메리카, 동유럽, 신흥 시장 및 기타 지역.
국가 독일, 영국, 프랑스, 스페인, 이탈리아, 러시아, 네덜란드, 튀르키예, 폴란드, 캐나다, 중국, 일본, 말레이시아, 싱가포르, 한국, 호주, 사우디아라비아, 브라질, 아르헨티나, 콜롬비아, 칠레, 페루, 남아프리카, 기타
Snibe Co. Ltd.(Shenzhen New Industries Biomedical Engineering Co. Ltd.)
Sonic Healthcare
Standard BioTools
Streck Inc.
Sysmex Corporation
Thermo Fisher Scientific Inc.
Tosoh Bioscience
Trinity Biotech PLC
Veracyte, Inc.
Verily Life Sciences LLC
Visiopharm
VolitionRx Limited
Werfen
Yourgene Health
제15장 기업 프로파일 : 제2층
장의 범위
BGI Genomics
MGI Tech Co., Limited, China
Biocartis
Diagnostica Stago SAS
Eiken Chemical Co., Ltd
Fujirebio Diagnostics, Inc.
Fulgent Genetics, Inc
Grifols SA
수혈사업
ABO식 혈액형
분자 ABO 혈액형 판정
면역 측정
시장 확대
자기 테스트
Guardant Health, Inc.
Horiba
Invitae(now Labcorp)
Menarini Diagnostics
Meridian Bioscience, Inc.
면역 측정
분자 검사
Myriad Genetics, Inc.
OraSure Technologies, Inc.
QIAGEN
Tuberculosis
분자의 팽창
정밀의료/동반진단
분자 미생물학
출생 전 검사
차세대 시퀀싱
디지털 PCR
액체 생검
자궁경부암
확대
Randox Laboratories Ltd
임상 화학
POC와 신속
동반진단
컨트롤
증거 시리즈 - 멀티 스탯 바이오칩 분석기
분자
Sekisui Diagnostics LLC
Veracyte, Inc.
제16장 기업 프로파일 : 혈액은행 전문 기관
장의 범위
AliveDx
Cerus Corporation
제17장 기업 프로파일 : 핵심 실험실 및 기타 기업
장의 범위
ARKRAY
드라이케미스트리/면역측정
소변 검사
당뇨병
분자
EKF Diagnostics Holdings Plc
ELITech Group SAS(part of Bruker)
SCIEX Pte Ltd.
Shimadzu Scientific Instruments
Snibe Co. Ltd.,(Shenzhen New Industries Biomedical Engineering Co. Ltd.)
Tosoh Bioscience
Trinity Biotech Plc
제18장 기업 프로파일 : CTC 및 액체 생검 검사 제공업체
장의 범위
Epic Sciences
Foundation Medicine, Inc.
NeoGenomics
제19장 기업 프로파일 : 전문기관
장의 범위
Ascensia Diabetes Care Holdings AG
Insulet Corporation
Medtronic plc
Verily Life Sciences LLC
제20장 기업 프로파일 : 혈액학(세포 분석) 및 응고 전문 기관
장의 범위
CellaVision AB
Masimo Corporation
Nova Biomedical Corporation(Nova)
제21장 기업 프로파일 : 조직병리학 전문기관
장의 범위
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc.(ASI)
Visiopharm
제22장 기업 프로파일 : 면역 측정 전문 기관
장의 범위
Biohit Healthcare
Biomerica Inc.
Bio-Techne Corporation
Eurobio Scientific
EUROIMMUN AG(Revvity)
Immunodiagnostic Systems(IDS)
INOVA Diagnostics, Inc.
VolitionRx Limited
제23장 기업 프로파일 : 미생물학 전문기관
장의 범위
Accelerate Diagnostics, Inc.
Advanced Biological Laboratories, SA(ABL)
altona Diagnostics
ArcDia International Oy Ltd.
COPAN ITALIA SpA and COPAN Diagnostics, Inc.
Genetic Analysis AS
Q-linea AB
Seegene, Inc.
제24장 기업 프로파일 : 분자 검사 전문 기관
장의 범위
Pacific Biosciences of California, Inc.(PacBio)
Standard BioTools
제25장 기업 프로파일 : 포인트 오브 케어 검사 전문 기관
장의 범위
Abingdon Health Ltd.
binx Health
Chembio Diagnostic Systems, Inc.
Genedrive plc
MedMira, Inc.
제26장 기업 프로파일 : 출생 전 검사 서비스 제공업체
장의 범위
Berry Genomics Co. ltd.
INEX Innovate
Oxford Gene Technology
Yourgene Health
제27장 기업 프로파일 : 품질 관리 및 샘플 전처리 전문 기관
장의 범위
10x Genomics
Agena Bioscience, Inc.
Biotype Diagnostic GmbH
IncellDx
LGC SeraCare Life Sciences, Inc.
PreAnalytiX GmbH
Precipio, Inc.
Quanterix Corporation
Streck Inc.
제28장 검사 서비스 제공업체
장의 범위
Agendia BV
Ambry Genetics
ARUP Laboratories
Aspira Women's Health
BioReference Laboratories
Blueprint Genetics Oy
Boston Heart Diagnostics
CareDx, Inc.
Predictive Oncology
Labcorp, Laboratory Corporation of America
Mayo Clinic Laboratories
MDxHealth SA
OPKO Diagnostics/Opko Health
Quest Diagnostics
Sonic Healthcare
KTH
영문 목차
영문목차
Kalorama Information's "The Worldwide Market for In Vitro Diagnostic (IVD) Tests", now in its 18th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2025 to 2030, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume.
Key Features:
Extensive Coverage: Detailed estimates and forecasts for every significant IVD test category, with chapters on Clinical Chemistry, Hematology, Histology, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, Point of Care (POC), and more.
In-Depth Analysis: Based on vendor reporting, interviews, and global activities, this 1,700-page report offers a full assessment of the IVD market.
Trusted Source: Published since 1999, it's the most trusted report by top companies in the IVD industry.
Growth Projections: Market size, future projections, and compound annual growth rates for all test segments through 2030.
Company Profiles: In-depth profiles of hundreds of companies, including the top 40, covering financial results, product launches, and strategic plans.
Global Scope: Analysis includes market size for every significant country and major market segments globally.
Essential Insights for Business Planning:
Market Size and Trends: Understand the size and breakdown of IVD market segments.
Future Projections: Forecasts for where these markets will be in five years.
Industry Changes: Track the evolution of the IVD market over time.
Competitive Landscape: Identify key players, mergers, and groundbreaking product launches.
Strategic Opportunities: Discover growth markets for potential entry or investment.
Country-Level Coverage:
This report reflects the global scope of the IVD market, covering:
Regions: US, Europe, Asia Pacific, Latin America, Eastern Europe, Emerging Markets, Rest of World.
Countries: Germany, UK, France, Spain, Italy, Russia, Netherlands, Turkey, Poland, Canada, China, Japan, Malaysia, Singapore, South Korea, Australia, Saudi Arabia, Brazil, Argentina, Colombia, Chile, Peru, South Africa, and more.
Table 2-6: Global Lab Market Segmentation, 2024 ($ billion) [Hospital and Acute Care Labs. Independent Labs, Physician Office Labs]
Quest
Labcorp
Table 2-7: Total Revenues for Leading U.S.-based Reference Labs, 2022-2024 ($ million) [Bio-Reference Lab/OPKO, Labcorp, Quest Diagnostics]
COVID-19 Market: Where We Are Now?
Figure 2-4: Combined Performance in COVID-19 and non-COVID-19 IVD Market Segments, 2020-2030 ($ million)
Chapter 3: IVD Market by Country and Region
Chapter Scope
Overview
Expected World IVD Market Developments
Global Population and Aging
Figure 3-1: Global Fertility Rate vs. Population Size, 1950-2050 (billion)
Figure 3-2: Global Population Distribution, 2025
Table 3-1: Elderly Support Ratio in Various Countries, 2010 and 2050 [Australia, Brazil, Canada, China, China (Hong Kong SAR), France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, Singapore, South Africa, Spain, Turkey, United Kingdom, United States, World]
Workforce Reduction
WHO Essential IVD List
Table 3-2: WHO Model List of Essential In Vitro Diagnostics (EDL)
Increase in Chronic Diseases
Figure 3-3: Leading Causes of Death Globally, 2021* (number of deaths in millions)
Emerging and Emerged Markets
Table 3-3: Developed/Developing Economies, UN Classification*, 2025
Figure 3-4: Developed vs. Developing IVD Market Shares, 2025 and Projected 2030 (%)
Table 3-4: Countries To Watch for IVD Opportunities, by Total Population and Percent Urban, 2025 [Australia, Brazil, China, France, Germany, Hungary, India, Mexico, Netherlands, Peru, Poland, Romania, Saudi Arabia, South Africa, South Korea, Sweden, Switzerland, Turkey, United Kingdom, United States]
Size and Forecast for the Global IVD Market by Country/Region
Table 3-5: Global In Vitro Diagnostic Market, Major Country/Region Markets, 2025 and 2030 ($ million) [Australia, Brazil, Canada, China, Eastern Europe, Western Europe, India, Japan, Mexico, Peru, Russia, Saudi Arabia, South Africa, South Korea, Turkey, UAE, United States, Vietnam, RoW]
Table 3-6: Global In Vitro Diagnostic Market, Regional Markets, 2025 and 2030 ($ million) [Africa, Asia Pacific, Europe, Latin America, Middle East, North America]
Table 3-7: Global In Vitro Diagnostic Market, YOY Growth, by Segment, 2024-2025 (%) [(Blood Bank Molecular, Blood Bank Screening - Immunoassays, Blood Grouping/Typing, Clinical Chemistry, Coagulation (PT/INR, Molecular), D-dimer, Diabetes HbA1c, Lab, Drugs of Abuse, Hematology - Core Lab, Histology/Cytology, Immunoassays - Infectious Disease, Immunoassays - Other Immunos, Mass Spectrometry (Micro/Non-Micro)Microbiology (ID/AST), Microbiology (Molecular), Molecular Oncology, Molecular Genetic/Inherited, POC, OTC Glucose OTC, POC Continuous Glucose, POC, OTC Other, POC, Professional/Hospital)]
Table 3-8: Global In Vitro Diagnostic Market, Regional Markets, 2024-2025 YOY Change (%) (Africa, Asia Pacific, Europe, Latin America, Middle East, North America]
Table 3-20: Asia Pacific Region IVD Market, by Country, 2025 ($ million) [Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Thailand, Vietnam]
Table 5-4: POC Pregnancy and Fertility Test Market Distribution, by End User, 2025 (%) [OTC, PRO]
Table 5-5: Pregnancy/Fertility POC Test Sales Distribution, by Global Region, 2025 (%) [Europe, Japan, United States, RoW]
Colon Cancer Screening
Table 5-6: Selected POC Colon Cancer Tests
Table 5-7: Colon Cancer POC Test Sales Distribution, by Global Region, 2025 (%) [Europe, Japan, United States, RoW]
Lipid Testing
Table 5-8: Lipid POC Test Sales Distribution, by Global Region, 2025 (%) [Europe, Japan, United States, RoW]
Drugs of Abuse (DOA) Testing
Table 5-9: POC Drugs of Abuse Test Sales Distribution, by Setting, 2025 (%) [Criminal Justice, Critical Care - Traditional POC, Employment Screening]
Products
Table 5-10: Drugs of Abuse Tests on the Market
Table 5-11: Drugs of Abuse POC Test Sales Distribution, by Global Region, 2025 (%) [Europe, Japan, United States, RoW]
POC Infectious Disease Testing
Molecular Point of Care
Table 5-12: Innovations in Molecular POC Infectious Disease Diagnostics
Rapid Products: Diverse Tech For Diverse Pathogens
Table 5-13: POC Infectious Disease Test Summary by Disease and Technology
POC HIV and Hepatitis Testing and Monitoring
POC Tuberculosis Tests
POC Tropical and Neglected Diseases Tests
Respiratory Diseases POC - Growth Means Competition
Sepsis and Nosocomial Disease
Sexually-Transmitted Infections (STI)
Sexually-Transmitted Infections POC: Binx, Visby, Now Shake Up Market
Lyme Disease
Table 5-14: Innovations in Molecular POC Infectious Disease Diagnostics
COVID-19
Table 5-15: Selected Antigen POC Home Immunoassay Tests for SARS-CoV-2
POC Infectious Disease Testing: Market Size and Growth
POC Infectious Disease Testing by Disease
Table 5-16: Infectious Disease POC Test Demand, by Type, 2025 ($ million) [C. difficile, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, Other Respiratory, STI, Others]
POC Infectious Disease Testing: Respiratory vs. Non-Respiratory
Table 7-14: Selected Inflammatory Bowel Disease Test Innovations
Transplant Management
Table 7-15: Selected Immunoassays for Transplant Medicine
Women's Health
Table 7-16: Selected Women's Health Innovations
Alzheimer's Disease
Table 7-17: Selected Innovations for Alzheimer's Disease Immunoassays
Traumatic Brain Injury
Miscellaneous
Table 7-18: Selected Immunoassay Innovations
Point-of-Care OTC and Professional Use Immunoassays
Table 7-19: Global POC Immunoassay Sales Distribution, by Region, 2025 (%) [Europe, Japan, United States, RoW]
Table 7-20: Global POC Immunoassay Test Sales, by Test Category, 2025-2030 ($ million) [OTC/Self Tests (Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Infectious Disease/COVID-19, Other) and Professional POC (Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Infectious Disease/COVID-19, Other)]
Table 7-23: Selected POC Immunoassay Test Platforms
The Commercial Outlook for Immunoassays
Chapter 8: Molecular Assays
Chapter Scope
Edition-Specific Notes
Overview
Table 8-1: Common Next Generation Molecular Test Traits
Sample Preparation and Quality Control
Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
Molecular Evolution
Exosome Sequencing
Table 8-3: Selected Exosome Test Innovations
Liquid Biopsy
Table 8-4: Selected Liquid Biopsy Innovations
Metabolomic Profiling
Information Technology
Table 8-5: Selected IT Innovations in Molecular Diagnostics
Artificial Intelligence (AI)
Forensic Studies - An Emerging Opportunity
Table 8-6: Selected Innovations in Forensic DNA Testing
Test Platforms
Table 8-7: Key Molecular Technologies and Major Players
Table 8-8: Selected Molecular Test Platform Innovations
Major Players
Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2022-2025 ($ million) estimated
Market Analysis
Table 8-10: Global Genomic, HLA and Oncology Molecular Test Sales, by Type with NIPT, 2025-2030 ($ million) [Genetic/Inherited Disease Assays, Oncology Assays (incl. CDx), Prenatal Testing - NIPT, Transplant Testing (HLA)]
Oncology
Table 8-11: Global Molecular Cancer Test Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Table 8-12: Selected Molecular Tumor Marker Test Innovations
Inherited/Genetic Diseases, Thrombophilia SNPs and Other Disorders
Table 8-13: Most Frequently Requested Genetic Tests
Table 8-14: Global Molecular Thrombophilia Assay Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Alzheimer's Disease and Dementia
Cardiovascular Disease
Table 8-15: Selected Genomic Tests for Inherited Diseases
Depression and Psychiatric Disorders
Prenatal and Newborn Testing
Table 8-16: Global Prenatal Test Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Table 8-17: Selected Prenatal Services Provided
Table 8-18: Selected Molecular Tests for Prenatal Analysis
Transplant Diagnostics
Table 8-19: Global Molecular HLA Testing Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Figure 8-1: Global Transplant Rate, by Region, 2024
Table 8-20: Selected Innovations of Molecular Transplant Diagnostics
Women's Health
The Commercial Outlook for Molecular Tests
Chapter 9: Hematology
Chapter Scope
Edition-Specific Notes
Overview of Hematology and Trends
Table 9-1: Hematology Analyzer Distribution of Unit Sales, by Menu Capability, 2025 estimated (%) [3-part diff analyzers, 5-part diff analyzers, Other analyzers]
Table 9-2: Lab-based Hematology Sales by Analyte Average Annual Distribution (%) [CBC, Hemoglobin, Other specialized]
Table 11-18: Selected Automated Molecular Test Instrument Platforms
Molecular Respiratory Infection Testing
The Respiratory Trio - Flu, Strep, RSV
Table 11-19: Selected COVID-19, Flu, RSV Tests
Other Developments - Beyond the Respiratory Trio, Sequencing
Molecular Testing for Sexually Transmitted Infections (STIs)
Molecular Hepatitis Testing
Molecular HIV Testing
Table 11-20: Innovations in Molecular POC Diagnostics for HIV
Molecular Tests for Hospital-Acquired Infections (HAIs)
Table 11-21: Frequency of the Most Common Nosocomial Infections
Assessing the Problem: Nosocomial Infection Statistics
Clostridium Difficile
MRSA
Molecular TB Testing
Limitations of Molecular Microbiology Testing
Mass Spectrometry Infectious Disease Testing
Table 11-22: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
The Future Outlook for Infectious Disease IVD
Chapter 12: Blood Banking Services
Chapter Scope
Edition-Specific Notes
Overview
The Current Status of Global Blood Collection
Global Blood Safety
Table 12-1: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries [Chagas, HBV, HCV, HIV, HTLV I/II1, Malaria, Syphilis]
Table 12-2: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
Zika Virus
Blood and Component Collection
Table 12-3: Blood Component Usage for Selected Conditions
Reevaluating Blood Transfusions
Table 12-4: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
Blood Typing and Grouping Market
Manual Blood Typing Methods
Automated Blood Typing and Screening Methods
Molecular Methods
Table 12-5: Selected Blood Typing and Grouping Innovations
Size and Growth of Typing Markets
Table 12-6: Global Blood Typing Market, 2025-2030 ($ million)
Blood Typing Market by Geography
Table 12-7: Global Blood Typing Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
HPV Testing: Clinical Significance, Technological Advances, and Global Market Trends
Table 13-4: Global HPV Test Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Table 13-5: Selected HPV Test Innovations
Market Analysis
Total Market for Histology and Cytology
Table 13-6: Global Histology/Cytology Sales by Type, 2025-2030 ($ million) [HPV, Immunohistochemistry, in situ hybridization, Pap Tests, traditional non-Pap stains]
Regional Market Analysis
Table 13-7: Global Histology/Cytology Sales Distribution, by Region, 2025 (%) [Asia Pacific, Europe, North America, RoW]
Table 13-8: Revenues of the Major Histology Companies, 2019-2025 ($ million, estimated)
Traditional Stains
Table 13-9: Selected Vendors of Traditional Histology Stains
Pap Testing
Table 13-10: Primary and Secondary Prevention of Cervical Cancer, Screening Responses, by Country, 2021
Figure 13-1: Three approaches to cervical cancer screening and future tests
Immunohistochemistry and In Situ Hybridization (IHC and ISH)
Table 13-11: Selected In Situ Hybridization-based Tests
